BFRA - Biofrontera AG - ADR
Previous close
2.67
0 0%
Share volume: 0
Last Updated: Fri 04 Mar 2022 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$2.67
0.00
0.00%
Summary score
33%
Profitability
26%
Dept financing
21%
Liquidity
28%
Performance
45%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
2.43%
Return on assets
-10.74%
Return on sales
-89.65%
Return on invested capital
77.54%
Total debt ratio
67.82%
Debt ratio change over timeo
-24.05%
Current Ratio
4.37%
Quick Ratio
3.73%
Cash Position Ratio
2.91%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
103.88%
Return on assets
-3.96%
Return on sales
-37.92%
Return on invested capital
-17.45%
Total debt ratio
91.95%
Debt ratio change over timeo
-94.4%
Current Ratio
2.19%
Quick Ratio
1.73%
Cash Position Ratio
1.24%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
594.16%
Return on assets
-7.23%
Return on sales
-85.64%
Return on invested capital
-28.39%
Total debt ratio
101.95%
Debt ratio change over time
-363.95%
Current Ratio
2.69%
Quick Ratio
2.22%
Cash Position Ratio
1.86%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-13305.26%
Return on assets
56.16%
Return on sales
1771.85%
Return on invested capital
607.02%
Total debt ratio
-2405.29%
Debt ratio change over time
-24.05%
Current Ratio
-59.02%
Quick Ratio
-48.76%
Cash Position Ratio
-43.52%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BFRA | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 2.43% | 0% | 0% | 26.83% |
| Return on assets | -10.74% | 0% | 0% | -10.24% |
| Return on sales | -89.65% | 0% | 0% | -1670.47% |
| Return on invested capital | 77.54% | 0% | 0% | 57.71% |
| Profitability | 27% | 0% | 50% | 44% |
| Total debt ratio | 67.82% | 0% | 0% | 168.24% |
| Debt ratio change over time | -24.05% | 0% | 0% | 17.84% |
| Dept financing | 10% | 0% | 0% | 50% |
| Current Ratio | 2.19% | 0% | 0% | 8.32% |
| Quick Ratio | 1.73% | 0% | 0% | 8.32% |
| Cash Position Ratio | 1.24% | 0% | 0% | 7.97% |
| Liquididy | 57% | 0% | 0% | 75% |
| Short-term ratios | BFRA | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 103.88% | 0% | 0% | -39.65% |
| Return on assets | -3.96% | 0% | 0% | -13.45% |
| Return on sales | -37.92% | 0% | 0% | -4352.39% |
| Return on invested capital | -17.45% | 0% | 0% | 120.66% |
| Profitability | 25% | 0% | 50% | 25% |
| Total debt ratio | 91.95% | 0% | 0% | 65.53% |
| Debt ratio change over time | -94.4% | 0% | 0% | 0.08% |
| Dept financing | 25% | 0% | 0% | 43% |
| Current Ratio | 2.19% | 0% | 0% | 8.32% |
| Quick Ratio | 1.73% | 0% | 0% | 8.32% |
| Cash Position Ratio | 1.24% | 0% | 0% | 7.97% |
| Liquididy | 16% | 0% | 0% | 75% |